The sequence specificity of the binding of barminomycin (SN-07 chromophore) to DNA was investigated using an in vitro transcription assay. It was found that this compound formed blockages to transcription, and these blocks were highly selective for 5′-GC sequences. The half-lives of the first seven transcriptional blockages at 37C were 14–130 min, plus one site>>200 min, with widely varying levels of essentially permanent blockages at each site (0–100%; average of 40%), indicative of considerable dependence on flanking sequences of adducts stability at individual GC sites. Barminomycin was also shown to form DNA virtual (i.e. functional) interstrand crosslinks. Such crosslinks were also relatively heat stable, with 40 % of the DNA rem...
International audienceA theoretical study is presented concerning DNA-anthramycin adducts. By explic...
Mitomycin C (MC), a quinone-containing cancer therapy agent, is biologically active by alkylating DN...
Includes vita.[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] Damage to DNA i...
The Adriamycin derivative, cyanomorpholinoadria-mycin (CMA) was reacted with DNA In vitro to form ap...
AbstractCyanomorpholinoadriamycin (1 μM) was reacted in a transcription buffer with DNA of an initia...
AbstractAdriamycin and mitomycin C were reduced by xanthine oxidase/NADH in the presence of a DNA te...
Thesis (Ph. D.)--University of Washington, 1999Duplex DNA incubated with adriamycin, dithiothreitol ...
The anticancer anthracycline compound Adriamycin is a known topoisomerase II inhibitor but is also c...
Mitomycin C, a clinically used chemotherapeutic agent, forms interstrand covalent cross-links in the...
Actinomycin D in low concentrations was suggested to inhibit ribosomal RNA (rRNA) transcription via ...
The antitumor activity of bleomycin is thought to arise from its ability to mediate DNA damage. Prev...
Aziridinomitosenes (AZMs) are organic molecules with high structural similarity to mitomycin C (MC),...
BackgroundMitomycin C (MC), a DNA cross-linking and alkylating agent, targets guanines in the m5CpG ...
Simplified synthetic azinomycins preferentially induce in vitro DNA interstrand cross-links at the s...
The DNA alkylating mechanism of PNU- 159682 (PNU), a highly potent metabolite of the anthracycline n...
International audienceA theoretical study is presented concerning DNA-anthramycin adducts. By explic...
Mitomycin C (MC), a quinone-containing cancer therapy agent, is biologically active by alkylating DN...
Includes vita.[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] Damage to DNA i...
The Adriamycin derivative, cyanomorpholinoadria-mycin (CMA) was reacted with DNA In vitro to form ap...
AbstractCyanomorpholinoadriamycin (1 μM) was reacted in a transcription buffer with DNA of an initia...
AbstractAdriamycin and mitomycin C were reduced by xanthine oxidase/NADH in the presence of a DNA te...
Thesis (Ph. D.)--University of Washington, 1999Duplex DNA incubated with adriamycin, dithiothreitol ...
The anticancer anthracycline compound Adriamycin is a known topoisomerase II inhibitor but is also c...
Mitomycin C, a clinically used chemotherapeutic agent, forms interstrand covalent cross-links in the...
Actinomycin D in low concentrations was suggested to inhibit ribosomal RNA (rRNA) transcription via ...
The antitumor activity of bleomycin is thought to arise from its ability to mediate DNA damage. Prev...
Aziridinomitosenes (AZMs) are organic molecules with high structural similarity to mitomycin C (MC),...
BackgroundMitomycin C (MC), a DNA cross-linking and alkylating agent, targets guanines in the m5CpG ...
Simplified synthetic azinomycins preferentially induce in vitro DNA interstrand cross-links at the s...
The DNA alkylating mechanism of PNU- 159682 (PNU), a highly potent metabolite of the anthracycline n...
International audienceA theoretical study is presented concerning DNA-anthramycin adducts. By explic...
Mitomycin C (MC), a quinone-containing cancer therapy agent, is biologically active by alkylating DN...
Includes vita.[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] Damage to DNA i...